Home › Funds › SECTOR GAMMA AS › VRDN

SECTOR GAMMA AS position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

SECTOR GAMMA AS reported holding 84,867 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.36% of its reported portfolio and ranking #41 among its reported holdings. SECTOR GAMMA AS first reported this position in Q3 2026.

Latest position (Q3 2026)84.87K sh
Reported value held$1.75M
Portfolio Weight0.36%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SECTOR GAMMA AS's VRDN position evolved

SECTOR GAMMA AS first disclosed a stake in VRDN in Q3 2026 at 84,867 shares (US$1.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 84.87K $1.75M New

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in VRDN — the largest reported positions include Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has SECTOR GAMMA AS held VRDN?

SECTOR GAMMA AS has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is SECTOR GAMMA AS's current position in VRDN?

As of Q3 2026, SECTOR GAMMA AS holds 84.87K shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $1.75M, representing 0.36% of its reported portfolio and ranking #41.

Has SECTOR GAMMA AS been buying or selling VRDN?

In the latest 13F filing (Q3 2026), SECTOR GAMMA AS newly opened its position in VRDN.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.